Perrigo Company

Client is an American Irish-registered manufacturer of private label OTC pharmaceuticals.

Based in MI

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $40K in lobbying spend across 4 quarterly filings, Perrigo Company is an active lobbying client. Their lobbying covers 3 issue areas.

$40K
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2025$40K

Issues Lobbied

AgricultureBudget/AppropriationsFood Industry

Lobbying Firms

Squire Patton Boggs

Lobbyists

David LesstrangMara Sheldon

Government Agencies Targeted

These are the government entities that Perrigo Company disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Agriculture, Budget/Appropriations, Food Industry

Public policy support regarding FDA oversight of infant formula.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Michigan Farm Bureau
$2.6M total spend
Learning Care Group
$1.1M total spend
Lineage (FKA Lineage Logistics)
$560K total spend
Thumb Cellular
$230K total spend
Henry Ford Museum and Greenfield Village
$150K total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.